Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|September 12, 2019
ADAM17-Mediated Reduction in CD14<sup>++</sup>CD16<sup>+</sup> Monocytes <i>ex vivo</i> and Reduction in Intermediate Monocytes With Immune Paresis in Acute Pancreatitis and Acute Alcoholic HepatitisKathryn Waller, Charlotte James, Anja de Jong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 3, 2025
A European Survey to Identify Challenges in the Management of Metabolic Dysfunction-Associated Steatotic Liver DiseaseLaurent Castera, William Alazawi, Elisabetta Bugianesi, et al.
Annals of Hepatology|December 4, 2024
A social media listening study of patients' experiences relating to metabolic dysfunction-associated steatotic liver disease: The LISTEN-MASLD studyJeffrey V Lazarus, William Alazawi, Ron Basuroy, et al.
Frontline Gastroenterology|October 26, 2017
Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional surveyDavid A Sheridan, Guru Aithal, William Alazawi, et al.
Frontline Gastroenterology|March 29, 2018
Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descentSampath De Silva, Wenhao Li, Polychronis Kemos, et al.
Annals of Surgery|May 29, 2015
Systemic Inflammatory Response Syndrome After Major Abdominal Surgery Predicted by Early Upregulation of TLR4 and TLR5Rajiv Lahiri, Yannick Derwa, Zora Bashir, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 5, 2026
Liver Stiffness Rises Early in MASLD and Drives Inflammation, Lipid Dysmetabolism, and Fibrosis via Piezo1-YAP MechanotransductionJuan Ma, Ning Xie, Ziwei Wang, et al.
Eclinicalmedicine|June 16, 2022
Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK BiobankFrederick K Ho, Lyn D Ferguson, Carlos A Celis-Morales, et al.
Nature Medicine|April 15, 2014
Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2Alastair J O'Brien, James N Fullerton, Karen A Massey, et al.
BMC Medicine|May 21, 2019
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohortsMyriam Alexander, A Katrina Loomis, Johan van der Lei, et al.
Pageof 6